| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023840976 |
| P356 | DOI | 10.1007/S11886-013-0372-4 |
| P698 | PubMed publication ID | 23644993 |
| P2093 | author name string | Alan Maisel | |
| Punam Chowdhury | |||
| Rajiv Choudhary | |||
| Devin Kehl | |||
| P2860 | cites work | Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation | Q74235980 |
| A novel biochemical approach to congestive heart failure: cardiac troponin T | Q77933851 | ||
| N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study | Q80428291 | ||
| [Assessment of renal function, iatrogenic hyperkalemia and acute renal dysfunction in cardiology. Contrast-induced nephropathy] | Q82220346 | ||
| Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? | Q84318543 | ||
| Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea | Q84646787 | ||
| Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure | Q84768406 | ||
| Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers | Q84769482 | ||
| Kidney injury molecule-1 correlates with kidney function in heart allograft recipients | Q85089699 | ||
| Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 | ||
| IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines | Q24294720 | ||
| High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure | Q24610732 | ||
| Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 | ||
| The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use | Q27000715 | ||
| Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial | Q28253329 | ||
| Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section | Q28269814 | ||
| Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction | Q28271905 | ||
| Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction | Q28274593 | ||
| Interleukin family member ST2 and mortality in acute dyspnoea | Q28292056 | ||
| Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure | Q28294246 | ||
| Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury | Q28294888 | ||
| Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate | Q28295117 | ||
| Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure | Q28575465 | ||
| IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system | Q28585033 | ||
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial | Q33526184 | ||
| Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative | Q33728260 | ||
| ABC of heart failure. Pathophysiology | Q33817181 | ||
| Adrenomedullin: potential in physiology and pathophysiology | Q33861509 | ||
| Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. | Q34005206 | ||
| In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. | Q34027034 | ||
| Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure | Q34032111 | ||
| The utility of troponin measurement to detect myocardial infarction: review of the current findings. | Q34139055 | ||
| Identification of serum soluble ST2 receptor as a novel heart failure biomarker | Q34176448 | ||
| Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. | Q34306146 | ||
| Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath | Q34347905 | ||
| Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction | Q34528187 | ||
| The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. | Q34580385 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| Galectin-3: a novel mediator of heart failure development and progression | Q34995162 | ||
| Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial | Q35128552 | ||
| Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. | Q35151512 | ||
| Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass | Q35563765 | ||
| Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure | Q35567128 | ||
| Neurohormonal activation in congestive heart failure and the role of vasopressin | Q36104992 | ||
| Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure | Q36315462 | ||
| Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate | Q36344899 | ||
| Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study | Q36365772 | ||
| Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells | Q36400414 | ||
| Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community | Q36439679 | ||
| Renal impairment and outcomes in heart failure: systematic review and meta-analysis | Q36477172 | ||
| Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study | Q36851584 | ||
| Clinical and subclinical cardiovascular disease and kidney function decline in the elderly | Q37228758 | ||
| Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function | Q37448863 | ||
| Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction | Q37591134 | ||
| Heart failure, chronic kidney disease, and biomarkers--an integrated viewpoint--. | Q37766057 | ||
| Troponin elevation in heart failure prevalence, mechanisms, and clinical implications | Q37791696 | ||
| Emerging biomarkers in heart failure | Q37956614 | ||
| Galectin-3: a novel blood test for the evaluation and management of patients with heart failure | Q37976301 | ||
| Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study | Q38487799 | ||
| Natriuretic peptides: Diagnostic and therapeutic use. | Q39581832 | ||
| Biomarkers for the early detection of acute kidney injury | Q39791593 | ||
| Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study | Q39808342 | ||
| Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort | Q39936653 | ||
| Cystatin C and mortality risk in the elderly: the health, aging, and body composition study | Q40375333 | ||
| ST2 protein induced by inflammatory stimuli can modulate acute lung inflammation | Q40689670 | ||
| Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation | Q41920449 | ||
| B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study | Q42040074 | ||
| Association of ST2 levels with cardiac structure and function and mortality in outpatients | Q42863640 | ||
| T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses | Q42944108 | ||
| Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure | Q43136870 | ||
| Association of cystatin C with left ventricular structure and function: the Dallas Heart Study. | Q43266267 | ||
| Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay | Q43287911 | ||
| Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid | Q43649877 | ||
| C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction | Q43795750 | ||
| Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction | Q44245130 | ||
| Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care. | Q44273778 | ||
| Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial | Q44360648 | ||
| Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction | Q44556884 | ||
| The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis | Q44615100 | ||
| Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury | Q44643853 | ||
| Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial). | Q44912714 | ||
| Prognostic utility of ST2 in patients with acute dyspnea and preserved left ventricular ejection fraction | Q44965235 | ||
| Performance characteristics of the ARCHITECT Galectin-3 assay. | Q45933388 | ||
| C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study | Q46061278 | ||
| Cardiac troponin-I and risk of heart failure: a community-based cohort study | Q46098837 | ||
| Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure | Q46177015 | ||
| Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure | Q46356815 | ||
| Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery | Q46423060 | ||
| Cardiac troponin and outcome in acute heart failure | Q46595726 | ||
| Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 | ||
| Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure | Q47863806 | ||
| Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time | Q48126208 | ||
| ANP is cleared much faster than BNP in patients with congestive heart failure | Q48179076 | ||
| Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. | Q48278579 | ||
| Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure | Q48399609 | ||
| Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study | Q48420596 | ||
| Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome | Q48946641 | ||
| Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease. | Q50620926 | ||
| Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. | Q53147437 | ||
| Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system. | Q54316452 | ||
| Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. | Q54702884 | ||
| Relation between cardiac troponin I and mortality in acute decompensated heart failure | Q57266843 | ||
| Recommendations for the use of cardiac troponin measurement in acute cardiac care | Q58314269 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| biomarker | Q864574 | ||
| patient | Q181600 | ||
| P304 | page(s) | 372 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | The use of biomarkers in the patient with heart failure | |
| P478 | volume | 15 |
| Q36046973 | Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure |
| Q51739297 | Cardiac complications of chemotherapy: role of biomarkers. |
| Q37108587 | Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy |
| Q27005797 | Clinical Significance of B-type Natriuretic Peptide in Heart Failure |
| Q36822397 | Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes |
| Q48283568 | Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials? |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q41074638 | Optimizing clinical use of biomarkers in high-risk acute heart failure patients |
| Q40311889 | Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure |
| Q37573138 | Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis |
| Q38466312 | Right ventricular myocardial biomarkers in human heart failure |
| Q34373840 | Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases |
| Q38194209 | The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure |
| Q38703882 | The current status of heart failure diagnostic biomarkers. |
| Q41385684 | The role of timely measurement of galectin-3, NT-proBNP, cystatin C and hsTnT in predicting prognosis and heart function after heart transplantation |
Search more.